Skip to content

MCH ANALYSIS RESEARCH Main site ↗

Industrials

Research & Consulting Services

7 companies under coverage.

How to read this page

Coverage

Research & Consulting Services

Equity Research

FTI Consulting Inc (FCN)

HOLD. 12-month probability-weighted target $156 (+14% vs spot). Gross Margin explains 70% of Monte Carlo outcome variance.

FCNEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +7.3%

Equity Research

TransUnion (TRU)

BUY. 12-month probability-weighted target $76 (+16% vs spot). P/E Multiple explains 64% of Monte Carlo outcome variance.

TRUEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +3.8%

Equity Research

Equifax Inc (EFX)

HOLD. 12-month probability-weighted target $153 (+5% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

EFXEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -5.8%

Equity Research

UL Solutions Inc. (ULS)

HOLD. 12-month probability-weighted target $69 (-2% vs spot). P/E Multiple explains 54% of Monte Carlo outcome variance.

ULSEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -13.2%

Equity Research

Booz Allen Hamilton Holding (BAH)

HOLD. 12-month probability-weighted target $76 (+2% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

BAHEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -13.8%

Equity Research

Verisk Analytics Inc (VRSK)

HOLD. 12-month probability-weighted target $178 (+0% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

VRSKEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -14.7%

Equity Research

Exponent Inc (EXPO)

SELL. 12-month probability-weighted target $62 (-11% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

EXPOEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -18.4%

MCH ANALYSIS · All research · Research, not personal financial advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed

MCH Analysis is a general investment-research publication of MCH Advisory (Pty) Ltd. It is not personal financial advice and does not take your circumstances into account. MCH is not a licensed financial services provider or a registered investment adviser. Past performance, whether actual or simulated, does not predict future results. Subscriber Agreement | Privacy and Cookie Notice | Research Governance Policies